Smart Respiratory

NHS Problem

Asthma and COPD affect 12% of the UK population and inhalers are our main therapeutic tools, costing the NHS £1 billion annually. Unfortunately, compliance with inhaler therapy is shockingly low and leads to the poorest asthma outcomes in Europe.  

In research studies, electronic inhaler monitoring is the gold standard for tracking compliance but the price of the devices has prohibited their adoption into clinical practice.  

This makes prescribing an ineffective and unnecessarily expensive process of trial-and-error, where every year 47% of patients have their inhaler regime changed, with NO DATA to guide the process. 

The Solution

Smart Respiratory has developed cost-effective sensors, a patient app, and a dashboard for clinicians – which have huge potential to address inhaler adherence, improve asthma control, reduce costs, and benefit the environment. 

Impact

Each inhaler step-up costs £300 per annum and therapy step-ups cost many times more. We know many of these step-ups are unnecessary but clinicians don’t have a good tool to assess compliance.

Smart Respiratory sensors provide a cost-effective way to check compliance and lung function at clinical decision points, thereby saving on drug costs and reducing side effects, specialist waiting lists and carbon footprint.